Premium Cigar Advertising

November 9, 2026 updated by: Ollie Ganz, DrPH, MSPH, Rutgers, The State University of New Jersey

Filling the Gaps: A Multi-Method Investigation of Premium Cigar Use and Marketing to Inform the Regulation of Cigar Products

The goal of this randomized online study is to learn how different features of premium cigar advertisements affect adults' perceptions of premium cigars and their intentions to purchase or use them. The main questions are whether advertisements that include hertiage claims, alcohol imagery, or manufcaturing claims affect perceptions of product appeal, taste, freshness, smoothness, quality, and health risks, and whether these features affect intentions to purchase and use the product.

Approximately 2,000 adults living in the United States who have used premium cigars in the past year will complete an online survey about demographics and tobacco use. Participants will be randomly assigned to one of four conditions. They will then view three premium cigar advertisements containing a specific feature (i.e., alcohol, brand heritage, manufacturing). A control group will view ads without these features. Participants will then answer questions about the advertisements, premium cigars, and their intentions to purchase or use them.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

2000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • used a premium cigar in the past year;
  • lives in the United States (participants complete the survey remotely from anywhere in the United States)
  • age 18 or older

Exclusion Criteria:

  • has not used a premium cigar in the past year;
  • does not live in the United States
  • under age of 18

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Alcohol imagery

Participants will view premium cigar ads with alcohol imagery

Participants view three randomly selected premium cigar advertisements that include alcohol imagery. After viewing each advertisement, participants answer questions about product perceptions, perceived health risks, appeal, and intentions to purchase or use premium cigars. At the end, they will view one of the 3 ads again (randomly selected) and will be asked questions about brand perceptions.

Experimental: Heritage theme

Participants will view premium cigar ads with brand heritage/tradition themes

Participants view three randomly selected premium cigar advertisements that feature language aligned with the theme of brand heritage. After viewing each advertisement, participants answer questions about product perceptions, perceived health risks, appeal, and intentions to purchase or use premium cigars. At the end, they will view one of the 3 ads again (randomly selected) and will be asked questions about brand perceptions.

Experimental: Manufacturing theme

Participants will view premium cigar ads with manufacturing imagery and language

Participants view three randomly selected premium cigar advertisements that include imagery and language related to the manufacturing of premium cigars. After viewing each advertisement, participants answer questions about product perceptions, perceived health risks, appeal, and intentions to purchase or use premium cigars. At the end, they will view one of the 3 ads again (randomly selected) and will be asked questions about brand perceptions.

Other: Control

Participants view three premium cigar advertisements that do not contain the experimental features being tested.

Participants view three randomly selected premium cigar advertisements that do not include the targeted alcohol, heritage, or manufacturing features. After viewing each advertisement, participants answer the same questions as participants in the other arms. At the end, they will view one of the 3 ads again (randomly selected) and will be asked questions about brand perceptions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intention to use
Time Frame: immediately after the intervention

Participants will be asked how likely they would be to buy the cigar featured in the ad

immediately after the intervention
Likelihood to purchase
Time Frame: immediately after the intervention

Participants will be asked how likely they are to purchase the cigar.

immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived harm
Time Frame: immediately after the intervention

Participants will be asked how harmful they think the premium cigar is featured in the ad

immediately after the intervention
Perceived addictiveness
Time Frame: immediately after the intervention

Participants will be asked how addictive they think the premium cigar is featured in the ad

immediately after the intervention
Product perceptions- tastes good
Time Frame: immediately after the intervention

Participants rate whether the advertised cigar might taste good

immediately after the intervention
Product perceptions- smell nice
Time Frame: immediately after the intervention

Participants rate whether the advertised cigar might smell nice

immediately after the intervention
Product perceptions- expensive
Time Frame: immediately after the intervention

Participants rate whether the advertised cigar appears expensive

immediately after the intervention
Product perceptions- high quality
Time Frame: immediately after the intervention

Participants rate whether the advertised cigar contains high quality tobacco

immediately after the intervention
Product perceptions- harsh
Time Frame: immediately after the intervention

Participants rate whether the advertised cigar appears harsh

immediately after the intervention
Product perceptions- fresh
Time Frame: immediately after the intervention

Participants rate whether the advertised cigar appears fresh

immediately after the intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brand perceptions- respected brand
Time Frame: immediately after the intervention

Participants rate whether the advertised brand appears respected.

immediately after the intervention
Brand perceptions- a brand with heritage
Time Frame: immediately after the intervention

Participants rate whether the advertised brand appears to be a brand with heritage

immediately after the intervention
Brand perceptions- reputable brand
Time Frame: immediately after the intervention

Participants rate whether the advertised brand appears reputable.

immediately after the intervention
Brand perceptions- trustworthy brand
Time Frame: immediately after the intervention

Participants rate whether the advertised brand appears trustworthy .

immediately after the intervention
Brand perceptions- authentic brand
Time Frame: immediately after the intervention

Participants rate whether the advertised brand appears authentic .

immediately after the intervention
Emotional response to advertisement- happy
Time Frame: immediately after the intervention

Participants rate how much viewing the advertisement made them feel happy

immediately after the intervention
Emotional response to advertisement- irritated
Time Frame: immediately after the intervention

Participants rate how much viewing the advertisement made them feel irritated

immediately after the intervention
Emotional response to advertisement- calm
Time Frame: immediately after the intervention

Participants rate how much viewing the advertisement made them feel calm

immediately after the intervention
Emotional response to advertisement- sad
Time Frame: immediately after the intervention

Participants rate how much viewing the advertisement made them feel sad

immediately after the intervention
Emotional response to advertisement- angry
Time Frame: immediately after the intervention

Participants rate how much viewing the advertisement made them feel angry

immediately after the intervention
Emotional response to advertisement- curious
Time Frame: immediately after the intervention

Participants rate how much viewing the advertisement made them feel curious

immediately after the intervention
Emotional response to advertisement- nostalgic
Time Frame: immediately after the intervention

Participants rate how much viewing the advertisement made them feel nostalgic

immediately after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Ollie Ganz, DrPH, Rutgers

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

November 3, 2026

First Submitted That Met QC Criteria

November 9, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro2025000061
  • R21DA062921 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We will share a single data file from the survey. Data collected will be anonymous and all personally identifying information will be removed. We will include a methodology statement, which will describe how the study was conducted, how respondents were sampled, and the characteristics of the study sample, and a codebook will be made publicly available to the research community. Codebooks will be prepared in compliance with the NAHDAP data repository. The codebook will include univariate statistics for each variable and each variable in the codebook will include a brief description of the item along with variable labels and value labels. Documentation will be provided in PDF.

IPD Sharing Time Frame

Final submission and release of the study data will occur approximately 12 months following the end of data collection, at the time of publication, or at the end of the award, whichever comes first, for each aim.

IPD Sharing Access Criteria

Data will be shared and deposited in the National Addiction & HIV Data Archive Program (NAHDAP) data depository hosted at the Inter-university Consortium for Political and Social Research (ICPSR).

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.